Australia pledges funding to find dementia breakthrough

8 August 2014
canberra-big

The Australian Minister for Health, Peter Dutton, has announced the opening of a new round of dementia research grants and invited groups of researchers to apply for the National Health and Medical Research Council’s (NHMRC) new Dementia Research Team Grants, worth up to A$6.5 million ($6.0 million) each over five years.

Mr Dutton made the announcement while visiting the Clem Jones Centre for Ageing and Dementia Research in Brisbane, Australia’s first and only facility entirely focused on research into the prevention and treatment of dementia. More than 300,000 Australians have dementia and it is forecast that will grow to one million by 2050. It is now the third leading cause of death and a recent survey found dementia had overtaken cancer as the most feared disease for adults over 55.

The research grants will support new research into big themes: the causes of dementia, improved methods of prevention and early diagnosis, new treatment options and ways to improve quality of life for patients and their carers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical